https://www.selleckchem.com/products/yo-01027.html
Hispanic/Latino (H/L) ethnicity is associated with higher prevalence of type 2 diabetes mellitus (T2DM) and more complications and comorbidities. Few studies of antihyperglycemic agents (AHAs) have compared H/L with non-H/L patients. Randomized controlled trials and observational studies have shown canagliflozin (CANA) is effective at lowering hemoglobin A1C (A1C). To describe characteristics and compare glycemic control between H/L and non-H/L patients with T2DM filling their first prescription for CANA. This retrospective cohort stud
Like
Comment
Share
